Suppr超能文献

利用工程化乳球菌菌株生产丙型肝炎颗粒疫苗候选物。

Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.

机构信息

AgResearch, Hopkirk Research Institute, Palmerston North, New Zealand.

出版信息

Appl Environ Microbiol. 2011 Dec;77(24):8516-22. doi: 10.1128/AEM.06420-11. Epub 2011 Oct 7.

Abstract

Vaccine delivery systems based on display of antigens on bioengineered bacterial polyester inclusions can stimulate cellular immune responses. The food-grade Gram-positive bacterium Lactococcus lactis was engineered to produce spherical polyhydroxybutyrate (PHB) inclusions which abundantly displayed the hepatitis C virus core (HCc) antigen. In mice, the immune response induced by this antigen delivery system was compared to that induced by vaccination with HCc antigen displayed on PHB beads produced in Escherichia coli, to PHB beads without antigen produced in L. lactis or E. coli, or directly to the recombinant HCc protein. Vaccination site lesions were minimal in all mice vaccinated with HCc PHB beads or recombinant protein, all mixed in the oil-in-water adjuvant Emulsigen, while vaccination with the recombinant protein in complete Freund's adjuvant produced a marked inflammatory reaction at the vaccination site. Vaccination with the PHB beads produced in L. lactis and displaying HCc antigen produced antigen-specific cellular immune responses with significant release of gamma interferon (IFN-γ) and interleukin-17A (IL-17A) from splenocyte cultures and no significant antigen-specific serum antibody, while the PHB beads displaying HCc but produced in E. coli released IFN-γ and IL-17A as well as the proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and IL-6 and low levels of IgG2c antibody. In contrast, recombinant HCc antigen in Emulsigen produced a diverse cytokine response and a strong IgG1 antibody response. Overall it was shown that L. lactis can be used to produce immunogenic PHB beads displaying viral antigens, making the beads suitable for vaccination against viral infections.

摘要

基于生物工程化细菌聚酯包含物上展示抗原的疫苗投递系统可以刺激细胞免疫应答。经过工程改造的食品级革兰氏阳性菌乳球菌(Lactococcus lactis)可以生产大量展示丙型肝炎病毒核心(HCc)抗原的球形聚羟基丁酸酯(PHB)包含物。在小鼠中,该抗原投递系统诱导的免疫应答与用 PHB 珠粒展示的 HCc 抗原(该 PHB 珠粒由大肠杆菌产生)、无抗原的 PHB 珠粒(由乳球菌或大肠杆菌产生)或直接用重组 HCc 蛋白接种进行了比较。所有用含有 HCc PHB 珠粒或重组蛋白的疫苗进行接种的小鼠的接种部位病变都最小,所有疫苗都混合在油包水乳剂佐剂 Emulsigen 中,而用重组蛋白和完全弗氏佐剂进行接种则在接种部位产生了明显的炎症反应。用乳球菌生产并展示 HCc 抗原的 PHB 珠粒接种产生了针对特定抗原的细胞免疫应答,从脾细胞培养物中显著释放了γ干扰素(IFN-γ)和白细胞介素-17A(IL-17A),但没有显著的针对特定抗原的血清抗体,而展示 HCc 但由大肠杆菌产生的 PHB 珠粒则释放了 IFN-γ、IL-17A 以及促炎细胞因子肿瘤坏死因子-α(TNF-α)和 IL-6,同时产生了低水平的 IgG2c 抗体。相比之下,Emulsigen 中的重组 HCc 抗原产生了多样化的细胞因子应答和强烈的 IgG1 抗体应答。总体而言,乳球菌可用于生产具有免疫原性的展示病毒抗原的 PHB 珠粒,使这些珠粒适合用于针对病毒感染的疫苗接种。

相似文献

1
Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.
Appl Environ Microbiol. 2011 Dec;77(24):8516-22. doi: 10.1128/AEM.06420-11. Epub 2011 Oct 7.
4
Novel particulate vaccines utilizing polyester nanoparticles (bio-beads) for protection against Mycobacterium bovis infection - a review.
Vet Immunol Immunopathol. 2014 Mar 15;158(1-2):8-13. doi: 10.1016/j.vetimm.2013.04.002. Epub 2013 Apr 30.
5
Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice.
Biotechnol Lett. 2019 Jul;41(6-7):867-872. doi: 10.1007/s10529-019-02695-1. Epub 2019 May 22.
7
Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination.
Microbiol Res. 2011 Feb 20;166(2):111-20. doi: 10.1016/j.micres.2010.02.002. Epub 2010 Mar 12.
8
Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity.
Appl Microbiol Biotechnol. 2013 May;97(10):4333-42. doi: 10.1007/s00253-013-4722-3. Epub 2013 Jan 31.
9
Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccines.
Int J Med Microbiol. 2016 Dec;306(8):624-632. doi: 10.1016/j.ijmm.2016.10.002. Epub 2016 Oct 13.

引用本文的文献

1
Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus.
NPJ Vaccines. 2023 Jul 14;8(1):102. doi: 10.1038/s41541-023-00695-x.
2
The Two Faces of Bacterial Membrane Vesicles: Pathophysiological Roles and Therapeutic Opportunities.
Antibiotics (Basel). 2023 Jun 14;12(6):1045. doi: 10.3390/antibiotics12061045.
3
Exploiting Polyhydroxyalkanoates for Biomedical Applications.
Polymers (Basel). 2023 Apr 19;15(8):1937. doi: 10.3390/polym15081937.
4
Precision-engineering of subunit vaccine particles for prevention of infectious diseases.
Front Immunol. 2023 Feb 3;14:1131057. doi: 10.3389/fimmu.2023.1131057. eCollection 2023.
5
Bacteria derived extracellular vesicles in the pathogenesis and treatment of gastrointestinal tumours.
Front Oncol. 2023 Jan 23;12:1103446. doi: 10.3389/fonc.2022.1103446. eCollection 2022.
6
A Polyhydroxyalkanoates-Based Carrier Platform of Bioactive Substances for Therapeutic Applications.
Front Bioeng Biotechnol. 2022 Jan 5;9:798724. doi: 10.3389/fbioe.2021.798724. eCollection 2021.
8
From Residues to Added-Value Bacterial Biopolymers as Nanomaterials for Biomedical Applications.
Nanomaterials (Basel). 2021 Jun 4;11(6):1492. doi: 10.3390/nano11061492.
9
Immunopotentiating and Delivery Systems for HCV Vaccines.
Viruses. 2021 May 25;13(6):981. doi: 10.3390/v13060981.
10
Polymeric nanoparticle vaccines to combat emerging and pandemic threats.
Biomaterials. 2021 Jan;268:120597. doi: 10.1016/j.biomaterials.2020.120597. Epub 2020 Dec 10.

本文引用的文献

1
Vaccination for hepatitis C virus: closing in on an evasive target.
Expert Rev Vaccines. 2011 May;10(5):659-72. doi: 10.1586/erv.11.55.
2
Vaccine adjuvants: putting innate immunity to work.
Immunity. 2010 Oct 29;33(4):492-503. doi: 10.1016/j.immuni.2010.10.002.
4
Bacterial polymers: biosynthesis, modifications and applications.
Nat Rev Microbiol. 2010 Aug;8(8):578-92. doi: 10.1038/nrmicro2354. Epub 2010 Jun 28.
5
Novel tuberculosis vaccines on the horizon.
Curr Opin Immunol. 2010 Jun;22(3):374-84. doi: 10.1016/j.coi.2010.04.006. Epub 2010 May 12.
7
Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination.
Microbiol Res. 2011 Feb 20;166(2):111-20. doi: 10.1016/j.micres.2010.02.002. Epub 2010 Mar 12.
9
Th17 cytokines and vaccine-induced immunity.
Semin Immunopathol. 2010 Mar;32(1):79-90. doi: 10.1007/s00281-009-0191-2. Epub 2010 Jan 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验